• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A three-dimensional model of influenza virus, porcine

Commonground

Senior Moderator



Russia: A three-dimensional model of influenza virus, porcine

25.05.09 17:44
Scientists from the Singapore Bioinformatics Institute have created a three-dimensional model of the core protein of influenza virus A/H1N1 - neyraminidazy that would allow a more precise definition of "weak spots" virus, and create new drugs and vaccines against the new flu. "

The group of scientists led by Dr. Sebastian Maurer-Straw has set the area of protein molecules in which the mutation occurred, and determine what resources would be effective against the virus.

All influenza A viruses are divided into types depending on the varieties of two key proteins, which are located on the surfaces of viral particles - virionov. This gemagglyutinin (marked H), responsible for the ability of the virus to penetrate into the cell, and neyraminidaza (N), related to its reproduction. The structure of these proteins vary from strain to strain. "Pork influenza" refers to the type of H1N1, avian flu - to the H5N1 (although there are other varieties of bird flu), and "normal" seasonal influenza, as a rule, is a type of H3N2.

Scientists have determined that the structure of the virus A/H1N1 neyraminidazy much more similar to a protein similar to avian influenza virus H5N1, a protein other than strains H1N1, including the strain that caused an epidemic "Spanish" in 1918. In addition, these mutations are made less effective previously developed types of vaccines directed against neyraminidazy. However, existing drugs for influenza, such as Tamiflu and Relenza, remain effective against the new flu. "

[Comment: What do these similaries mean? Is this something to be concerned about?]
 
Re: A three-dimensional model of influenza virus, porcine

That is very very cool. I'm relying on those among us that understand all of this, to let me now when a mutation has occurred. :magnify:
 
Re: A three-dimensional model of influenza virus, porcine

Two D screen capture of the H1N1 virus from link in Lizw post.

2D H1N1 virus 20090526.webp
 
Re: A three-dimensional model of influenza virus, porcine

Two D screen capture of the H1N1 virus from link in Lizw post.

Thank you! I was reluctant to attach something with Java code in it, and never thought of doing a screencap.
 
Re: A three-dimensional model of influenza virus, porcine

<meta http-equiv="Content-Type" content="text/html; charset=utf-8"><meta name="ProgId" content="Word.Document"><meta name="Generator" content="Microsoft Word 10"><meta name="Originator" content="Microsoft Word 10"><link rel="File-List" href="file:///D:%5CDOCUME%7E1%5CADMINI%7E1%5CLOCALS%7E1%5CTemp%5Cmsohtml1%5C01%5Cclip_filelist.xml"><o:smarttagtype namespaceuri="urn:schemas-microsoft-com:office:smarttags" name="stockticker"></o:smarttagtype><!--[if gte mso 9]><xml> <o:OfficeDocumentSettings> <o:RelyOnVML/> <o:AllowPNG/> </o:OfficeDocumentSettings> </xml><![endif]--><!--[if gte mso 9]><xml> <w:WordDocument> <w:View>Normal</w:View> <w:Zoom>0</w:Zoom> <w:Compatibility> <w:BreakWrappedTables/> <w:SnapToGridInCell/> <w:WrapTextWithPunct/> <w:UseAsianBreakRules/> </w:Compatibility> </w:WordDocument> </xml><![endif]--><!--[if !mso]><object classid="clsid:38481807-CA0E-42D2-BF39-B33AF135CC4D" id=ieooui></object> <style> st1\:*{behavior:url(#ieooui) } </style> <![endif]--><style> <!-- /* Style Definitions */ p.MsoNormal, li.MsoNormal, div.MsoNormal {mso-style-parent:""; margin:0cm; margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman"; mso-fareast-font-family:"Times New Roman"; mso-ansi-language:EN-GB;} @page Section1 {size:612.0pt 792.0pt; margin:72.0pt 90.0pt 72.0pt 90.0pt; mso-header-margin:35.4pt; mso-footer-margin:35.4pt; mso-paper-source:0;} div.Section1 {page:Section1;} --> </style><!--[if gte mso 10]> <style> /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman";} </style> <![endif]--> As you say very cool.
<o:p> </o:p>
If you select Ostelamivir (red) and turn off everything else except the antigenic sites (green) it is amazing how they are clustered around the binding pocket. The upshot of this is that if there are changes that confer <st1:stockticker>NA</st1:stockticker> inhibitor resistance they are likely to have the compound effect of reducing vaccine effectiveness as well. I knew this was the case (due to a paper Florida1 sent me a link for on another subject which I can not now find) but it was interesting to see it so graphical illustrated (sorry about the pun).
<o:p> </o:p>
Niman has commented that the seasonal vaccine committee have not changed the vaccine composition of the H1 component to update it to an Ostelamivir resistant strain as the Brisbane/59 component was still the circulating strain but having seen this I am wondering if that was wise and if we should have updated to a drug resistant variant ? even if it means having to find a PR/8 combo that grows well.
<o:p> </o:p>
PS it is editable so if you find a new change it the coming weeks you can input it into the model and see where it falls relative to other sites of interest.
 
Back
Top Bottom